S6K1 and 4E-BP1 Are Independent Regulated and Control Cellular Growth in Bladder Cancer
Roman Nawroth(TUM Klinikum), Margitta Retz(Klinikum rechts der Isar)
Cited by 92
Related Papers
Parallel PI3K, AKT and mTOR inhibition is required to control feedback loops that limit tumor therapy
|PLoS ONE|2018|51
Mutant PIK3CA controls DUSP1-dependent ERK 1/2 activity to confer response to AKT target therapy
|British Journal of Cancer|2014|38
Functional genomics identifies predictive markers and clinically actionable resistance mechanisms to CDK4/6 inhibition in bladder cancer
|Journal of Experimental & Clinical Cancer Research|2019|34
Combination of Talazoparib and Palbociclib as a Potent Treatment Strategy in Bladder Cancer
|Journal of Personalized Medicine|2021|14
Oncolytic virotherapy provides a potent therapy option for squamous bladder cancer
|Scientific Reports|2025|3